Strides Pharma Science Limited (NSE:STAR)

Strides Pharma Science Revenue

Strides Pharma Science had revenue of 12.65B INR in the quarter ending June 30, 2026, with 13.01% growth. This brings the company's revenue in the last twelve months to 50.04B, up 8.07% year-over-year. In the fiscal year ending March 31, 2026, Strides Pharma Science had annual revenue of 48.59B with 6.43% growth.

• Revenue (ttm): 50.04B
• Revenue Growth: +8.07%
• P/S Ratio: 1.89
• Revenue / Employee: 14.16M
• Employees: 3,535
• Market Cap: 94.48B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	48.59B	2.93B	6.43%
Mar 31, 2025	45.65B	6.75B	17.36%
Mar 31, 2024	38.90B	2.02B	5.47%
Mar 31, 2023	36.88B	6.18B	20.13%
Mar 31, 2022	30.70B	-2.46B	-7.41%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error